TMEM206 gene knockout improves balance performance in SCA1 transgenic mice

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Spinocerebellar ataxia type 1 (SCA1) is a progressive, autosomal dominant neurodegenerative disorder caused by CAG repeat expansions in the ataxin-1 gene.
• TMEM206 is identified as a proton-activated chloride channel with a known interaction with ataxin-1.
• The interaction between TMEM206 and ataxin-1 suggests a potential role in SCA1 pathogenesis.

Purpose of the Study:

• To investigate the role of TMEM206 in the pathological mechanisms of SCA1.
• To elucidate the mechanisms of SCA1 involving proton-activated chloride channel gating.
• To evaluate the therapeutic potential of TMEM206 knockout in SCA1.

Main Methods:

• Generation of TMEM206 knockout mice crossed with SCA1 model mice (Atxn1^154Q/2Q).
• Assessment of motor coordination and balance using rotarod tests.
• Evaluation of grip strength in the genetically modified mice.

Main Results:

• Genetic depletion of TMEM206 had minimal impact on the body weight of SCA1 mice.
• TMEM206 knockout partially ameliorated motor incoordination in Atxn1^154Q/2Q mice.
• No significant alteration in grip strength was observed in SCA1 mice lacking TMEM206.

Conclusions:

• The interaction between TMEM206 and ataxin-1 is implicated in SCA1 pathology.
• TMEM206 knockout demonstrates a potential therapeutic strategy for SCA1.
• Further research into TMEM206's role in SCA1 may reveal novel treatment avenues.